List of works - Chiara F Magnani

Acquired glucose sensitivity of k-ras transformed fibroblasts.

scientific article

Acute myeloid leukemia and novel biological treatments: monoclonal antibodies and cell-based gene-modified immune effectors

scientific article published on 25 September 2013

Advanced targeted, cell and gene-therapy approaches for pediatric hematological malignancies: results and future perspectives

scientific article published on 30 April 2013

Balance of Anti-CD123 Chimeric Antigen Receptor Binding Affinity and Density for the Targeting of Acute Myeloid Leukemia

scientific article published on 3 May 2017

Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells

scientific article

Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway

scientific article

Donor-derived CD19-targeted T cells in allogeneic transplants

scientific article published on 18 September 2015

Enforced IL-10 expression confers type 1 regulatory T cell (Tr1) phenotype and function to human CD4(+) T cells.

scientific article

Engineered T cells towards TNFRSF13C (BAFFR): a novel strategy to efficiently target B-cell acute lymphoblastic leukaemia

scientific article published on 18 August 2017

Erratum: Corrigendum: Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells

Immunotherapy of acute leukemia by chimeric antigen receptor-modified lymphocytes using an improved Sleeping Beauty transposon platform

scientific article published on 13 June 2016

Killing of myeloid APCs via HLA class I, CD2 and CD226 defines a novel mechanism of suppression by human Tr1 cells.

scientific article published on 13 May 2011

Preclinical Efficacy and Safety of CD19CAR Cytokine-Induced Killer Cells Transfected with Sleeping Beauty Transposon for the Treatment of Acute Lymphoblastic Leukemia.

scientific article

Redirecting T cells with Chimeric Antigen Receptor (CAR) for the treatment of childhood acute lymphoblastic leukemia

scientific article published on 23 August 2017

Role of human leukocyte antigen-G in the induction of adaptive type 1 regulatory T cells.

scientific article published on 04 August 2009

TNFRSF13C (BAFFR) positive blasts persist after early treatment and at relapse in childhood B-cell precursor acute lymphoblastic leukaemia

scientific article published in June 2017

Targeting of acute myeloid leukaemia by cytokine-induced killer cells redirected with a novel CD123-specific chimeric antigen receptor.

scientific article

Therapeutic and diagnostic applications of minor histocompatibility antigen HA-1 and HA-2 disparities in allogeneic hematopoietic stem cell transplantation: a survey of different populations.

scientific article published in January 2006

List of works by Chiara F Magnani

Acquired glucose sensitivity of k-ras transformed fibroblasts.

Acute myeloid leukemia and novel biological treatments: monoclonal antibodies and cell-based gene-modified immune effectors

Advanced targeted, cell and gene-therapy approaches for pediatric hematological malignancies: results and future perspectives

Balance of Anti-CD123 Chimeric Antigen Receptor Binding Affinity and Density for the Targeting of Acute Myeloid Leukemia

Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells

Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway

Donor-derived CD19-targeted T cells in allogeneic transplants

Enforced IL-10 expression confers type 1 regulatory T cell (Tr1) phenotype and function to human CD4(+) T cells.

Engineered T cells towards TNFRSF13C (BAFFR): a novel strategy to efficiently target B-cell acute lymphoblastic leukaemia

Erratum: Corrigendum: Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells

Immunotherapy of acute leukemia by chimeric antigen receptor-modified lymphocytes using an improved Sleeping Beauty transposon platform

Killing of myeloid APCs via HLA class I, CD2 and CD226 defines a novel mechanism of suppression by human Tr1 cells.

Preclinical Efficacy and Safety of CD19CAR Cytokine-Induced Killer Cells Transfected with Sleeping Beauty Transposon for the Treatment of Acute Lymphoblastic Leukemia.

Redirecting T cells with Chimeric Antigen Receptor (CAR) for the treatment of childhood acute lymphoblastic leukemia

Role of human leukocyte antigen-G in the induction of adaptive type 1 regulatory T cells.

TNFRSF13C (BAFFR) positive blasts persist after early treatment and at relapse in childhood B-cell precursor acute lymphoblastic leukaemia

Targeting of acute myeloid leukaemia by cytokine-induced killer cells redirected with a novel CD123-specific chimeric antigen receptor.

Therapeutic and diagnostic applications of minor histocompatibility antigen HA-1 and HA-2 disparities in allogeneic hematopoietic stem cell transplantation: a survey of different populations.